RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioLine RX Stock

BioLine RX Net Income 2024

BioLine RX Net Income

-60.61 M USD

Ticker

BLRX.TA

ISIN

IL0011015182

In 2024, BioLine RX's profit amounted to -60.61 M USD, a 142.93% increase from the -24.95 M USD profit recorded in the previous year.

The BioLine RX Net Income history

YEARNET INCOME (undefined USD)
2023-60.61
2022-24.95
2021-27.05
2020-30.02
2019-25.45
2018-22.96
2017-24.35
2016-15.84
2015-14.4
2014-11.09
2013-17.04
2012-19.81
2011-14.04
20101.99
2009-15.69
2008-32.08
2007-14.48
2006-12.93
2005-6.31
2004-2.46

BioLine RX Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BioLine RX, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BioLine RX from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BioLine RX’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BioLine RX. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BioLine RX’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BioLine RX’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BioLine RX’s growth potential.

BioLine RX Revenue, EBIT and net profit per share

DateBioLine RX RevenueBioLine RX EBITBioLine RX Net Income
20234.8 M undefined-42.99 M undefined-60.61 M undefined
20220 undefined-29.16 M undefined-24.95 M undefined
20210 undefined-24.78 M undefined-27.05 M undefined
20200 undefined-22.93 M undefined-30.02 M undefined
20190 undefined-28.11 M undefined-25.45 M undefined
20180 undefined-25.61 M undefined-22.96 M undefined
20170 undefined-25.24 M undefined-24.35 M undefined
20160 undefined-16.51 M undefined-15.84 M undefined
20150 undefined-16.2 M undefined-14.4 M undefined
20140 undefined-17.16 M undefined-11.09 M undefined
20130 undefined-16.99 M undefined-17.04 M undefined
20120 undefined-21.19 M undefined-19.81 M undefined
20110 undefined-16.41 M undefined-14.04 M undefined
201030.33 M undefined3.52 M undefined1.99 M undefined
200916.3 M undefined-16.14 M undefined-15.69 M undefined
20080 undefined-33.31 M undefined-32.08 M undefined
20070 undefined-21.8 M undefined-14.48 M undefined
20060 undefined-13.06 M undefined-12.93 M undefined
20050 undefined-6.86 M undefined-6.31 M undefined
20040 undefined-2.25 M undefined-2.46 M undefined

BioLine RX stock margins

The BioLine RX margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioLine RX. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioLine RX.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BioLine RX's sales revenue. A higher gross margin percentage indicates that the BioLine RX retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BioLine RX's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BioLine RX's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BioLine RX's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BioLine RX. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BioLine RX's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BioLine RX Margin History

BioLine RX Gross marginBioLine RX Profit marginBioLine RX EBIT marginBioLine RX Profit margin
202323.08 %-895.65 %-1,262.79 %
202223.08 %0 %0 %
202123.08 %0 %0 %
202023.08 %0 %0 %
201923.08 %0 %0 %
201823.08 %0 %0 %
201723.08 %0 %0 %
201623.08 %0 %0 %
201523.08 %0 %0 %
201423.08 %0 %0 %
201323.08 %0 %0 %
201223.08 %0 %0 %
201123.08 %0 %0 %
201077.38 %11.61 %6.56 %
200964.6 %-99.02 %-96.26 %
200823.08 %0 %0 %
200723.08 %0 %0 %
200623.08 %0 %0 %
200523.08 %0 %0 %
200423.08 %0 %0 %

BioLine RX Aktienanalyse

What does BioLine RX do?

BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding BioLine RX's Profit Margins

The profit margins of BioLine RX represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of BioLine RX's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating BioLine RX's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

BioLine RX's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When BioLine RX’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about BioLine RX stock

How much profit has BioLine RX made this year?

BioLine RX has made -60.61 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 142.93% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does BioLine RX publish its earnings?

BioLine RX publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of BioLine RX?

The profits of BioLine RX are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of BioLine RX?

You can learn more about the earnings of BioLine RX by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does BioLine RX pay?

Over the past 12 months, BioLine RX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioLine RX is expected to pay a dividend of 0 USD.

What is the dividend yield of BioLine RX?

The current dividend yield of BioLine RX is .

When does BioLine RX pay dividends?

BioLine RX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioLine RX?

BioLine RX paid dividends every year for the past 0 years.

What is the dividend of BioLine RX?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioLine RX located?

BioLine RX is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioLine RX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioLine RX from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did BioLine RX pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of BioLine RX in the year 2023?

In the year 2023, BioLine RX distributed 0 USD as dividends.

In which currency does BioLine RX pay out the dividend?

The dividends of BioLine RX are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioLine RX

Our stock analysis for BioLine RX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLine RX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.